Concepedia

Wolfgang Wostl

WW

Statistics

Publications

10

Citations

824

H-Index

10

Active since

1991

Affiliations

Roche (Switzerland)(Current)

Rheinmetall (Switzerland)

Actelion (Switzerland)

Wolfgang Wostl is an author at Roche (Switzerland) specializing in pharmacology, medicinal chemistry, and renin-angiotensin system inhibitors.

Publications per year

1991–2013

10

Publications

10

Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma

Lucienne Juillerat‐Jeanneret, Jérôme Célérier, Catherine Chapuis Bernasconi et al. · British Journal of Cancer · 2004 · 145 citations · Full text

, , +16

β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease

Hans Hilpert, Wolfgang Guba, Thomas J. Woltering et al. · Journal of Medicinal Chemistry · 2013 · 137 citations · Full text

, , +17

Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?

Christian Oefner, Alfred Binggeli, Volker Breu et al. · Chemistry & Biology · 1999 · 126 citations · Full text

, , +6

Ro 42-5892 is a potent orally active renin inhibitor in primates.

Walter Fischli, Jean‐Paul Clozel, K el Amrani et al. · Hypertension · 1991 · 101 citations

, , +17

Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site

Eric Vieira, Alfred Binggeli, Volker Breu et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 95 citations · Full text

, , +16

1–5 of 10